| For: | Lau MS, Tsai HH. Review of vedolizumab for the treatment of ulcerative colitis. World J Gastrointest Pharmacol Ther 2016; 7(1): 107-111 [PMID: 26855816 DOI: 10.4292/wjgpt.v7.i1.107] |
|---|---|
| URL: | https://www.wjgnet.com/2150-5349/full/v7/i1/107.htm |
| Number | Citing Articles |
| 1 |
Eoin P. Cummins, Daniel Crean. Hypoxia and inflammatory bowel disease. Microbes and Infection 2017; 19(3) doi: 10.1016/j.micinf.2016.09.004
|
| 2 |
Yafang Li, Minli Hu, Yuan Chen, Xiao-Yun Yang, Qunying Wang, Jin Ding, Yibing Hu. Vedolizumab: Beyond Inflammatory Bowel Disease. Medical Principles and Practice 2025; 34(5) doi: 10.1159/000547015
|
| 3 |
Pedro Boal Carvalho, José Cotter. Mucosal Healing in Ulcerative Colitis: A Comprehensive Review. Drugs 2017; 77(2) doi: 10.1007/s40265-016-0676-y
|
| 4 |
Ali Abdullah Mohammed Alajlan, Ahmad Asri Awad Alanazi, Abdulrahman Ibrahim Abdullah Al Fahad, Abdullah Saleh Abdullah Almorshed, Abdullah Abdulrahman Mohammed Alrbian, Majed Ali Mohammed Alsawaji, Nawal Haif Bajad Al-Mutairi, Sanytan Ghazy Al Otaibi. The impact of biologics on the management of autoimmune diseases: A comprehensive review for pharmacists. International journal of health sciences 2018; 2(S1) doi: 10.53730/ijhs.v2nS1.15289
|
| 5 |
Jianfang Zhang, Xiaomin Chen, Xinyi Mu, Mengwei Hu, Jiang Wang, Xiaojun Huang, Shaoping Nie. Protective effects of flavonoids isolated from Agrocybe aegirita on dextran sodium sulfate‐induced colitis. eFood 2021; 2(6) doi: 10.53365/efood.k/147240
|
| 6 |
Alexandre Jentzer, Anne-Emmanuelle Depincé-Berger, Christian Genin, Xavier Roblin, Stéphane Paul. Nouveaux marqueurs diagnostiques et pronostiques des maladies chroniques inflammatoires intestinales. Revue Francophone des Laboratoires 2016; 2016(484) doi: 10.1016/S1773-035X(16)30223-4
|
| 7 |
Vipul Jairath, Alessandro Armuzzi, Christian Agboton, Brian Bressler, Silvio Danese, Parambir S. Dulai, Marlies Meyer, Itzel Romo Bautista, Raja Atreya, Brian G. Feagan. A decade of clinical data with vedolizumab: the past, present, and future. Therapeutic Advances in Gastroenterology 2026; 19 doi: 10.1177/17562848261448962
|
| 8 |
Anjali B. Ganjare, Nishikant Raut, Ravindra Satpute, Shailju Gurunani. Evaluation of protective effect of the hydroalcoholic extract of aerial parts of Amaranthus spinosus on acetic acid induced colitis in mice via modulating inflammatory markers and oxidative stress. Journal of Ethnopharmacology 2025; 349 doi: 10.1016/j.jep.2025.119902
|
| 9 |
Lei Zhu, Lu-Ming Dai, Hong Shen, Pei-Qing Gu, Kai Zheng, Ya-Jun Liu, Lu Zhang, Jia-Fei Cheng. Qing Chang Hua Shi granule ameliorate inflammation in experimental rats and cell model of ulcerative colitis through MEK/ERK signaling pathway. Biomedicine & Pharmacotherapy 2019; 116 doi: 10.1016/j.biopha.2019.108967
|
| 10 |
Jasmina El Hadad, Philipp Schreiner, Thomas Greuter. Update zur medikamentösen Therapie der Colitis ulcerosa. Schweizer Gastroenterologie 2023; 4(1) doi: 10.1007/s43472-023-00092-8
|
| 11 |
Her Hsin Tsai. Dose escalation of vedolizumab in inflammatory bowel disease patients with secondary loss of response. GastroHep 2021; 3(2) doi: 10.1002/ygh2.448
|
| 12 |
Amy Hsin-Chieh Hsieh, Mutaz Ferman, Michael P Brown, Jane M Andrews. Vedolizumab: a novel treatment for ipilimumab-induced colitis. BMJ Case Reports 2016; 2016 doi: 10.1136/bcr-2016-216641
|
| 13 |
Azza Abdelfattah Ali, Ekram Nemr Abd Al Haleem, Sahar Abdel-Hafeez Khaleel, Amany Said Sallam. Protective effect of cardamonin against acetic acid-induced ulcerative colitis in rats. Pharmacological Reports 2017; 69(2) doi: 10.1016/j.pharep.2016.11.002
|
| 14 |
Congcong Li, Lu Wang, Juebo Zhao, Yucai Wei, Shuo Zhai, Min Tan, Kuikui Guan, Zhihong Huang, Chaoxi Chen. Lonicera rupicola Hook.f.et Thoms flavonoids ameliorated dysregulated inflammatory responses, intestinal barrier, and gut microbiome in ulcerative colitis via PI3K/AKT pathway. Phytomedicine 2022; 104 doi: 10.1016/j.phymed.2022.154284
|